Brief: Amphastar Pharmaceuticals Q4 EPS USD 0.51
26/02/2026 21:05
Feb 26 (Reuters) - Amphastar Pharmaceuticals Q4 adjusted EPS USD 0.73 vs. IBES estimate USD 0.92. Q4 net income USD 24.429 million Q4 adjusted net income USD 34.158 million vs. IBES estimate USD 43.6 million Q4 revenue USD 183.105 million vs. IBES estimate USD 190.5 million
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing